Zhao Dayu gave up treatment for advanced liver cancer

summary

A while ago, I often stayed up late to play with my mobile phone. I found that my liver was a little painful. I thought it was caused by fire, but I didn't pay much attention to it. Later, it became more and more painful. I couldn't stand the pain, so I went to the hospital to have a check-up to learn that I had liver cancer. The body has recovered a little. Do you have Zhao Dayu's experience in giving up treatment for advanced liver cancer? Share with me that Zhao Dayu gave up treatment for advanced liver cancer.

Zhao Dayu gave up treatment for advanced liver cancer

Treatment 1: surgical treatment, (1) general condition of the patient: ① good general condition, no serious damage to heart, lung and kidney function, it is estimated that the patient can tolerate the operation: ② good liver function compensation, or only mild damage, according to the liver function grade 1; or grade II, after short-term liver protection treatment, the liver function recovered to grade I; ③ no extensive extrahepatic metastatic tumor. (2) Radical resection can be performed in the following cases: ① single small or small hepatocellular carcinoma; ② single large or huge extrahepatic hepatocellular carcinoma, with smooth surface and clear boundary, less than 1 / 3 of liver tissue damaged by tumor; ③ multiple tumor, with less than 3 tumor nodules, and limited to one lobe or a section of liver.

Treatment 2: B-ultrasound or CT guided percutaneous tumor pain relief therapy, B-ultrasound or CT guided percutaneous tumor puncture, radiofrequency, microwave, freezing or injection of anhydrous alcohol therapy, as well as in vitro high frequency focused ultrasound and other local physical therapy. These methods are suitable for the patients with small tumor, especially for the patients with early recurrence after hepatectomy. It has the advantages of definite curative effect, safety, convenience and less side effect. Some patients can get better treatment effect.

Treatment 3: chemotherapy, in principle, does not do systemic chemotherapy. Selective regional chemotherapy, such as isolated perfusion through hepatic artery, portal vein or liver, may improve the curative effect and reduce the toxic and side effects of chemotherapy. What is valuable is that selective regional chemotherapy after operation can prevent recurrence, which has been confirmed by many parties.

matters needing attention

The harm of alcohol abuse is great, especially for hepatitis B virus carriers. There are more males than females in patients with liver cancer, and the ratio of males to females is about 3 to 1. There are two reasons for this. On the one hand, androgen receptor is related to the incidence of liver cancer, but the main problem is that the proportion of male patients with hepatitis B is much higher than that of female patients. Alcohol is an important cause of hepatitis B cirrhosis. Studies have shown that for patients without hepatitis B, alcohol has little effect on liver damage, but for patients with hepatitis B, alcohol can cause obvious damage to the liver, which is an important cause of liver cirrhosis.